Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) Given Consensus Recommendation of Moderate Buy by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 8,190,000 shares, a growth of 15.7% from the December 31st total of 7,080,000 shares. Approximately 30.8% of the company’s stock are short sold. Based on an […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) has received a consensus recommendation of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have covered the stock in the […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) shares hit a new 52-week high during trading on Monday . The company traded as high as $15.60 and last traded at $15.17, with a volume of 96702 shares changing hands. The stock had previously closed at $14.81. Wall Street Analyst Weigh In PHAT has been the […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Rating)’s stock price shot up 1.7% during mid-day trading on Thursday . The stock traded as high as $13.11 and last traded at $13.02. Approximately 9,885 shares changed hands during trading, a decline of 98% from the average daily volume of 418,411 shares. The stock had previously closed at […]